Shanghai-based Qiao Peng at R&P China Lawyers is a former global compliance director at pharmaceutical and biotechnology giant AstraZeneca; Peng’s compliance practice covers advice to multinationals on commercial bribery, The Foreign Corrupt Practices Act, data privacy and fraud, along with internal control systems and compliance investigations.
Legal 500 Editorial commentary